Articles by Amy Ritter - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Amy Ritter

FDA Introduces New Safety Measures for Opioid Medications

Jul 11, 2012

On July 9, 2012, FDA approved a risk evaluation and mitigation strategy for extended-release and long-acting opioid medications.

GSK Agrees to $3 Billion Settlement with Justice Department

Jul 3, 2012

GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve criminal and civil liability resulting from unlawful promotion of certain drugs, failure to report safety data, and alleged false price reporting practices.

35th Anniversary Special: Advances in Protein Expression

Improvements in expression platforms and enhanced tools for selecting clones are among the advances of the past few decades.
Jul 2, 2012

Improvements in expression platforms and enhanced tools for selecting clones are among the advances of the past few decades.

35th Anniversary Special: Nanoformulations

A look back at key nanoformulation advances and what lies ahead for nanoparticle-based drug-delivery systems.
Jul 2, 2012

A look back at key nanoformulation advances and what lies ahead for nanoparticle-based drug-delivery systems.

US Supreme Court Upholds Individual Mandate for Health Insurance

Jun 28, 2012

In a 5-4 ruling, the US Supreme Court upheld the provision of the Affordable Care Act requiring all adults to purchase health insurance or pay a penalty—the so-called individual mandate.

Roche to Close US R&D Site

Jun 27, 2012

Roche announced that it will be closing its R&D site in Nutley, New Jersey, eliminating approximately 1000 positions.

Eli Lilly Expands Manufacturing Base in China

Jun 13, 2012

Eli Lilly announced an increase in its manufacturing network in China through an expanded collaboration with Novast Laboratories, a generic and specialty pharmaceutical company based in Nantong, China.

Takeda Completes Acquisition of URL Pharma

Jun 6, 2012

Takeda Pharmaceuticals announced that it has completed the acquisition of URL Pharma for an upfront payment of $800 million.

Looking for Fingerprints: Bioanalytical Characterization of Biosimilars

Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.
Jun 2, 2012

Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here